Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3270071 | HPB | 2010 | 12 Pages |
Abstract
Our data support the notion that HCV-related lipid metabolic abnormalities may contribute to hepatic steatosis and the development of cancer. Identification of these aberrations would stratify patients and improve treatment algorithms.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Jian-Min Wu, Nicholas J. Skill, Mary A. Maluccio,